In prostate cancer decreased levels of circulating S1P was reported during prostate cancer progression potentially stemming from a significant decrease in erythrocyte SphK1 levels, and this S1P decrease correlates with high prostate specific antigen (PSA) levels, lymph node status and may be an early marker for androgen independent tumors [339]. Here, KLK3 is linked to Familial prostate cancer.